Legacy Med Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
- Paid Up Capital ₹ 2.02 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 100.03%
- Profit Growth -114.11%
- Ebitda 143.94%
- Net Worth -1.68%
- Total Assets 107.11%
About Legacy Med
Legacy Med Private Limited (LMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 April 2012 and has a history of 12 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Legacy Health India Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.02 M, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Butani, Kan Butani, and Damodaran Jayavelu serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900TN2012PTC085368
- Company No.
085368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Legacy Med?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Butani  | Director | 10-Apr-2012 | Current |
| Kan Butani | Director | 10-Apr-2012 | Current |
Damodaran Jayavelu  | Director | 15-Mar-2018 | Current |
Financial Performance of Legacy Med.
Legacy Med Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 100.03% increase. The company also saw a substantial fall in profitability, with a 114.11% decrease in profit. The company's net worth dipped by a decrease of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Legacy Med?
In 2023, Legacy Med had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medvance Health Private LimitedDinesh Butani, Kan Butani and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Legacy Med?
Legacy Med has a workforce of 821 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Legacy Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Legacy Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.